Replies to post #90692 on $heff's $tation of $tocks & $olid DD

[BioHunter]

$MACK

Zohan,


MACK was way oversold and has generally had a strong bid under $10, so not surprising to see it pop on Friday. I don't think it's one to get greedy on, mostly due to some debate about their drugs commercial viability. My personal view is watch the trading next couple days and have a quick trigger on profits or taking a smaller loss on a bounce back. Looking back on my notes from some prior bio markets sell offs, after the carnage had stopped, the traditional runup FDA catalyst trades were less robust and importantly happened very close to the FDA catalyst date vs the more typical 30 days +/- runups. My assumption is traders are pretty bruised and more risk averse so runups become later and less robust if at all.

IMO

-BioHunter